Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of different CalliSpheres irinotecan bead sizes for unresectable colorectal liver metastases
ChiCTR2100046454Phase 4Recruiting
- Sponsor
- Yantai Yuhuangding Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of irinotecan in colorectal cancer (CRC) (2 arms), sponsored by Yantai Yuhuangding Hospital. Primary endpoint: objective response rate. Started May 2021; status: recruiting.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2100046454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046454.